Have a question? Book your consultation on WhatsApp — we reply in minutes.

Book on WhatsApp
Wegovy (Semaglutide) in Thailand — Physician-Led GLP-1 Program
Recommandé par le Médecin
GLP-1 Program

Wegovy (Semaglutide) in Thailand — Physician-Led GLP-1 Program

Healthi Life · Ekkamai 10, Bangkok

Semaglutide is a GLP-1 receptor agonist approved for chronic weight management. At Healthi Life in Thailand, Wegovy is delivered as a physician-supervised, biomarker-monitored program with contraindication review at every step. Prescription medicine.

À partir deOn request

Indicative — confirmed at physician consultation

Physician-Supervised
Biomarker-Monitored
Prescription Only
Ekkamai, Bangkok

Ce Qui Est Inclus

Physician consultation and contraindication review
Baseline and follow-up biomarker monitoring
Injection training and monthly clinical follow-up
Pourquoi Choisir Ce Protocole

How Semaglutide Works

GLP-1 Receptor Agonist

Semaglutide activates the GLP-1 receptor to support satiety, glycemic control and appetite regulation.

Physician-Supervised

Initiated and titrated by a licensed physician at Healthi Life Ekkamai.

Biomarker-Monitored

Baseline and follow-up labs (HbA1c, lipids, hepatic, renal) frame every dose adjustment.

Contraindication Review

Personal and family history screening before initiation, including MTC and MEN-2 exclusion.

Subcutaneous Injection

Weekly subcutaneous administration with in-clinic injection training and adherence support.

Longevity Integration

Coordinated with metabolic, hormone and biomarker programs for long-term outcomes.

Est-Ce Fait Pour Vous ?

Idéal Pour

  • Adults with BMI ≥ 30, or ≥ 27 with a weight-related comorbidity
  • Guests who have not reached goals with diet and lifestyle alone
  • Candidates committed to monthly follow-up and biomarker review

Non Recommandé Pour

  • Pregnant, planning pregnancy, or breastfeeding women
  • Personal or family history of medullary thyroid carcinoma (MTC) or MEN-2
  • History of pancreatitis or severe gastrointestinal disease
Votre Parcours

Our 4-Step Wegovy Program

1

Medical Intake

Full history, medication review, and contraindication screening with the physician.

2

Baseline Biomarkers

HbA1c, lipid panel, hepatic and renal function established before the first dose.

3

Titration

Progressive dose escalation 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg based on tolerability.

4

Monthly Follow-Up

Clinical review, side-effect assessment and dose adjustment every four weeks.

Excellence Médicale

Pourquoi Faire Confiance à Healthi Life

Protocoles dirigés par des médecins, certifications internationales et un engagement envers la sécurité des guests à Bangkok.

ISO 9001:2015 Certified Partner Labs
GMP Compliant Partner Laboratory
Thai Medical Council Registered
International Guest Safety Standards
Programmes

Choisissez Votre Programme

Wegovy 0.25 mg

On request

  • Starter / titration dose
  • Physician consultation
  • Injection training & biomarker review
Sélectionner ce Programme

Wegovy 0.5 mg

On request

  • Early titration dose
  • Physician consultation
  • Injection training & biomarker review
Sélectionner ce Programme
RECOMMANDÉ

Wegovy 1.0 mg

On request

  • Maintenance entry dose
  • Physician consultation
  • Injection training & biomarker review
Sélectionner ce Programme

Wegovy 2.4 mg

On request

  • Full maintenance dose
  • Physician consultation
  • Injection training & biomarker review
Sélectionner ce Programme
FAQ

Questions Fréquemment Posées

At Healthi Life Ekkamai, Wegovy (Semaglutide 2.4 mg) is prescribed for physician-supervised chronic weight management. It is initiated only after medical intake, contraindication review and baseline biomarker assessment.

Wegovy pricing at Healthi Life is provided on consultation, as supply and dose change month to month. Each dose includes physician consultation, injection training and biomarker review. Wegovy is prescription only.

Both contain Semaglutide and target the GLP-1 receptor. Ozempic is approved for type 2 diabetes (up to 2.0 mg weekly); Wegovy is approved for chronic weight management (up to 2.4 mg weekly). They are manufactured by Novo Nordisk under different brand indications.

Mounjaro (Tirzepatide) is a dual GIP/GLP-1 receptor agonist. Wegovy (Semaglutide) targets GLP-1 only. A physician at Healthi Life determines which molecule aligns with the individual's metabolic profile, contraindications and clinical goals.

Wegovy is a prescription medicine and must be initiated by a licensed physician. At Healthi Life Bangkok, prescription is preceded by medical history review, contraindication screening and baseline laboratory testing.

The most reported effects in clinical trials (STEP program) are nausea, diarrhea, vomiting, constipation and decreased appetite, typically during titration. Rare but serious risks include pancreatitis and gallbladder disease; report symptoms early.

Medically reviewed by Dr. Petch & Dr. First

Dr. Petch — International Board of Lifestyle Medicine (IBLM) — Diplomate

Dr. First — Dermatologist & Peptides Specialist

Last reviewed: July 1, 2026

Cette page fournit une information générale et ne constitue ni un avis médical, ni un diagnostic, ni un traitement. Les résultats varient d'une personne à l'autre. Consultez toujours un médecin qualifié au sujet de votre état de santé. Voir notre avertissement médical complet.

Book a Wegovy Consultation

Speak with a physician at Healthi Life Ekkamai for eligibility review, baseline biomarkers and a personalized titration plan.

Localisation

94 Ekkamai 10 Alley, Khlong Tan Nuea, Watthana, Bangkok 10110

5 min by taxi from BTS Ekkamai

Horaires

Mon-Sat: 11:00 AM – 7:00 PM

Temps de réponse : moins de 2 heures